Nam Huh / AP

Abbott Labs has reached a revised $5.3 billion agreement to purchase of Massachusetts-based diagnostic test maker Alere Inc. (NYSE: ALR).

Why it's a big deal: Because a proooooloooonged legal battle is finally over, as Abbott had originally agreed to buy Alere back in February 2016. But Abbott soon changed its mind, claiming that Alere had made various misrepresentations. Alere later sued to push the merger forward, which resulted in a countersuit from Abbott. The revised deal values Alere stock at $51 per share, a 20.5% premium to Thursday's closing price, but well below the original $56 per share agreement. All lawsuits will be dropped.

Bottom line: "Medical-device manufacturers have undergone consolidation as they come under pressure from hospitals and health systems to cut prices." ― Edward Robinson, Bloomberg.

Go deeper

Caitlin Owens, author of Vitals
2 mins ago - Health

The coronavirus is starting to crush some hospitals

Illustration: Aïda Amer/Axios

Some states are seeing dangerous levels of coronavirus hospitalizations, with hospitals warning that they could soon become overwhelmed if no action is taken to slow the spread.

Why it matters: Patients can only receive good care if there's enough care to go around — which is one reason why the death rate was so much higher in the spring, some experts say.

Scoop: The Lincoln Project is becoming a media business

Illustration: Eniola Odetunde/Axios

The Lincoln Project is looking to beef up its media business after the election, sources tell Axios.

Driving the news: The group recently signed with the United Talent Agency (UTA) to help build out Lincoln Media and is weighing offers from different television studios, podcast networks and book publishers.

Trump, Biden strategies revealed in final ad push

Data: Bully Pulpit Interactive; Chart: Danielle Alberti/Axios

President Trump is pouring hundreds of thousands of dollars into Facebook ads on the Supreme Court and conservative judges in the final stretch of his campaign, while Joe Biden is spending over a million on voter mobilization, according to an analysis by Axios using data from Bully Pulpit Interactive.

The big picture: Trump's Facebook ad messaging has fluctuated dramatically in conjunction with the news cycle throughout his campaign, while Biden's messaging has been much more consistent, focusing primarily on health care and the economy.